MedCity News August 3, 2020
GoodRx, a startup that makes tools for comparing the price of prescription drugs, is looking to go public, according to a report by Reuters. The company reportedly submitted paperwork to the Securities and Exchange Commission.
Prescription discount startup GoodRx is reportedly preparing to go public. The company filed initial paperwork for a potential IPO with the Securities and Exchange Commission, according to anonymous sources cited by Reuters.
The listing could take place later this year or in early 2021.
GoodRx, which was founded in 2011, offers drug discounts to self-pay customers and has a prescription price comparison tool. The company brings in revenue through referral fees from pharmacy benefit managers such as CVS as well as advertising.
The company has...
Today's Sponsors
Today's Sponsor